Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a cutting-edge, scalable nanoparticle (NP) production system in the ...

He's ventured far outside of his swim lane,' Cantor Fitzgerald analysts say. 'It's time to take him out of the pool.' Two Wall Street analysts on Monday called on the Trump administration to ...

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T entering Phase 3 ...

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.

Disturbing news appears nearly daily from the federal government. Among the science-related issues, the most disturbing was ...

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

Shares of some U.S. biotechnology companies including Moderna plunged on Monday after reports that the top vaccine official at the U.S. Food and Drug Administration (FDA) had resi ...

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...

Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the ...

Stock futures edged lower on Monday due to trade war concerns and the upcoming 25% levy on non-US cars. President Trump has ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...